A blockbuster gene-editing tool has been linked to cancer — here"s how worried you should be

American Cancer Society/Getty Images Bold headlines linking blockbuster gene-editing tool CRISPR to cancer sent stocks in companies trying to bring the technology to medicine tumbling. But scientists who study the technique sa.....»»

Category: topSource: businessinsiderJun 13th, 2018

A blockbuster gene editing tool could cause more damage than experts thought

Bobby Yip/Reuters A new study has concluded that genetic editing tool, CRISPR-Cas9, can cause significantly greater havoc than exp.....»»

Category: topSource: businessinsiderJul 16th, 2018

Scientists Just Found a Novel, Cheap Way to Use CRISPR Gene Editing to Fight Cancer

The CRISPR research was backed by Sean Parker's cancer immunotherap.....»»

Category: europeSource: fortuneJul 12th, 2018

CRISPR-related stocks sink after report that gene-editing technology might cause cancer

Shares of gene-therapy companies sank in active trade Monday, after a STAT report that editing a cell’s genome with CRISPR/Cas9 technology might cause cancer......»»

Category: topSource: marketwatchJun 11th, 2018

CRISPR Crashes After Study Highlights Potential Cancer Risk From Gene-Editing

Don't mess with mother nature.. or crowded longs! Crispr Therapeutics led gene-editing stocks lower after new studies published by Nature Medicine found that cells whose genomes are edited with the CRISPR-Cas9 technology have the po.....»»

Category: blogSource: zerohedgeJun 11th, 2018

Scientists can use CRISPR to edit genes. Should they?

Bill Whitaker reports on the gene-editing tool this week on 60 Minutes. The debate over how to use it is playing out in labs around the world.....»»

Category: topSource: moneycentralApr 30th, 2018

A Third Of The Great Barrier Reef Is Gone—Can Gene Editing Help Preserve The Rest?

By using a tool known as CRISPR-Cas9, scientists may be able to identify corals that are genetically predisposed to survive as the climate changes around them......»»

Category: topSource: newsweekApr 23rd, 2018

Roche takes on Loxo, Bayer in gene-defined cancer class - Reuters

ReutersRoche takes on Loxo, Bayer in gene-defined cancer classReutersMUNICH (Reuters) - Roche'.....»»

Category: topSource: googlenews2 hr. 5 min. ago

The Real Danger of Diabetes

The Real Danger of Diabetes The increased risk of health conditions like cardiovascular disease, cancer and kidney disorders have been linked with diabetes and early death, a new stud.....»»

Category: topSource: livetradingnewsOct 17th, 2018

Google AI Tool Can Spot Breast Cancer More Accurately Than Humans

In its quest to make AI more useful, Google has come up with a new algorith.....»»

Category: blogSource: valuewalkOct 15th, 2018

Google’s AI Tool Can Identify One Type of Breast Cancer More Accurately Than Human Doctors

Deep learning could save time in the doctor's office. Determining whether cancer has spread, or metastasized, from the primary site to nearby lymph nodes is a difficult, time-intensive task for pathologists. Google AI has d.....»»

Category: europeSource: fortuneOct 15th, 2018

Stocks End Horrible Week on a High Note

Stocks End Horrible Week on a High Note SPECIAL NOTE: The gene editing field provides big-gain potential, but investors must remain vigilant as the science, controversies and patent .....»»

Category: smallbizSource: nytOct 15th, 2018

Scientists Breed A Mouse Using Same-Sex Parents

Scientists in China used new gene editing technology which allowed them to breed a mouse from same-sex parents. This method, although slightly bizarre, will help scientists better understand how mammalian reproduction .....»»

Category: blogSource: valuewalkOct 12th, 2018

The First Mice Bred from 2 Dads Died Gruesome Deaths—But They May Hold Clues to Saving Endangered Species

New gene-editing method could allow researchers to design mice with same-sex parents. Using a gene-editin.....»»

Category: europeSource: fortuneOct 12th, 2018

Why Cancer Biotech Allogene Just Scored an Eye Popping $324 Million IPO

The blockbuster public offering pegs Allogene's market value at more than $2 billion. Biotech’s red-hot IPO streak shows no signs of slowing down. In fact, on Thursd.....»»

Category: europeSource: fortuneOct 11th, 2018

Gene editing could bring the groundcherry to your supermarket

The groundcherry could wind up in U.S. stores after scientists spliced its D.....»»

Category: topSource: usatodayOct 4th, 2018

A study of nearly half a million people revealed that eating certain types of food is linked to cancer — but there"s a simple fix

Shutterstock A new study of 471,495 European adults found that people who eat bigger portions and consume more meat, junk food, and alcohol have higher rates of cancer. Conversely, people whose diets are filled with vegetables, leg.....»»

Category: topSource: businessinsiderSep 21st, 2018

Brainstorm Health: Telehealth’s Road Blocks, CRISPR ViaCyte Diabetes Partnership, Low-Dose Aspirin Study

Brainstorm Health Daily: September 17, 2018 Happy Monday, readers--I hope you had a wonderful weekend. This is Sy. Some news from the land of CRISPR gene-editing to st.....»»

Category: europeSource: fortuneSep 17th, 2018

These Companies Want to Combine Stem Cells and CRISPR Gene Editing to Treat Diabetes

CRISPR Therapeutics is teaming up with ViaCyte in a futuristic diabetes deal. Some news from the land of CRISPR gene-ed.....»»

Category: europeSource: fortuneSep 17th, 2018

Gilead Inks Gene Editing Collaboration Deal for HBV Infection

Gilead (GILD) enters into a strategic collaboration with Precision BioSciences for developin.....»»

Category: smallbizSource: nytSep 13th, 2018

Gene-editing patent challenge rejected by Federal Circuit appeals court

See the rest of the story here. provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 10th, 2018